How cytoglobin affects blood vessel relaxation and blood pressure
Role of Cytoglobin in the Regulation of Vascular Tone
This research looks at whether changing cytoglobin activity can help blood vessels relax better and lower blood pressure for people with cardiovascular conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11228782 on NIH RePORTER |
What this research studies
The team studies cytoglobin, a protein in smooth muscle that helps control how quickly nitric oxide is broken down inside blood vessel walls. They use laboratory experiments on isolated vessels, molecular studies of cytoglobin's interactions and reducing systems, and testing of newly found inhibitors that block cytoglobin's nitric oxide–consuming activity without harming its antioxidant role. Prior work showed these inhibitors increase nitric oxide signaling in vessels, and the current work aims to clarify how cytoglobin controls vascular tone and blood pressure. The research includes experiments that could lead to animal or future human studies to see if targeting cytoglobin lowers blood pressure.
Who could benefit from this research
Good fit: People with hypertension or other blood vessel disorders would be the most likely candidates for future therapies or clinical studies based on this work.
Not a fit: Patients whose blood-pressure problems stem from causes unrelated to vascular nitric oxide signaling may not benefit from cytoglobin-targeted approaches.
Why it matters
Potential benefit: If successful, this could lead to new ways to improve vessel relaxation and treat high blood pressure.
How similar studies have performed: Earlier lab studies from this group found cytoglobin controls nitric oxide breakdown and discovered inhibitors that increased nitric oxide signaling in vessels, but these findings have not yet been proven to help patients.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Zweier, Jay Louis — Ohio State University
- Study coordinator: Zweier, Jay Louis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.